Dopaminergic regulation of peptide gene expression in the striatum of normal and parkinsonian monkeys.
Parent
A
A
Centre de Recherche en Neurobiologie, Hôpital de l'Enfant-Jésus, Québec, Canada.
Asselin
M C
MC
Côté
P Y
PY
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D000818:Animals; D001345:Autoradiography; D004298:Dopamine / Q000502:physiology*; D015259:Dopamine Agents; D004745:Enkephalins / Q000096:biosynthesis / Q000235:genetics; D005786:Gene Expression Regulation / Q000502:physiology*; D007150:Immunohistochemistry; D017072:Neostriatum / Q000378:metabolism* / Q000473:pathology; D009479:Neuropeptides / Q000096:biosynthesis* / Q000235:genetics*; D010302:Parkinson Disease, Secondary / Q000139:chemically induced / Q000378:metabolism* / Q000473:pathology; D011498:Protein Precursors / Q000096:biosynthesis / Q000235:genetics; D012453:Saimiri; D015320:Tachykinins / Q000096:biosynthesis / Q000235:genetics; D014446:Tyrosine 3-Monooxygenase / Q000235:genetics / Q000378:metabolism
D015259:Dopamine Agents; D004745:Enkephalins; D009479:Neuropeptides; D011498:Protein Precursors; D015320:Tachykinins; C044206:preprotachykinin; C033660:preproenkephalin; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; D014446:Tyrosine 3-Monooxygenase; D004298:Dopamine